首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1461494

全球週边血管器械市场规模、份额、成长分析（按产品类型、应用、最终用户）- 产业预测，2024-2031 年

Global Peripheral Vascular Devices Market Size, Share, Growth Analysis, By Product Type, By Application(Peripheral artery disease, deep vein thrombosis ), By End user - Industry Forecast 2024-2031

出版日期: 2024年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球週边血管器械市场规模为108.6亿美元，从2023年的114.5亿美元成长到2031年的174.3亿美元，在预测期内（2024-2031年）预计复合年增长率为5.4。

用于诊断和治疗週边血管疾病的医疗器材的开拓、生产和分销都是充满活力且快速扩张的全球週边血管器材市场的一部分。透过治疗静脉曲张、深层静脉栓塞症和周边动脉疾病(PAD) 等多种疾病，该行业正在为改善患者治疗效果做出重大贡献。人口老化和血管疾病盛行率的增加正在增加全世界对尖端、高效的周边血管设备的需求。週边血管设备市场的存在是为了向医疗保健专业人员提供用于诊断和治疗血管疾病的尖端设备和技术。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

美敦力（美国）
波士顿科学公司（美国）
雅培实验室（美国）
库克医疗（美国）
康迪斯公司（美国）
泰尔茂株式会社（日本）
贝克顿迪金森公司（美国）
强生公司（美国）
CR巴德（美国）
康德乐（美国）
血管动力学（美国）
Penumbra, Inc.（美国）
WL Gore & Associates（美国）
Endologix（美国）
微创医疗科技有限公司 (中国)
BTG plc（英国）
Spectranetics 公司（美国）
泰利福公司（美国）
爱德华兹生命科学公司（美国）
伦巴第医疗技术（英国）

简介目录

Product Code: SQMIG35A2529

Global Peripheral Vascular Devices Market size was valued at USD 10.86 billion in 2022 and is poised to grow from USD 11.45 billion in 2023 to USD 17.43 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

The development, production, and distribution of medical devices used in the diagnosis and treatment of peripheral vascular illnesses are all included in the dynamic and quickly expanding global market for peripheral vascular devices. By treating a variety of ailments such varicose veins, deep vein thrombosis, and peripheral artery disease (PAD), this industry significantly contributes to better patient outcomes. The need for cutting-edge and efficient peripheral vascular devices is growing globally due to an aging population and an increase in the prevalence of vascular disorders. The peripheral vascular devices market exists to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of vascular diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Vascular Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Vascular Devices Market Segmental Analysis

Global Peripheral Vascular Devices Market is segmented on the basis of product type, application, end user, and region. By product type, the market is segmented into angioplasty balloons, stents, embolic protection devices, peripheral vascular catheters, atherectomy devices, and vascular closure devices. By application, the market is segmented into peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and arteriovenous fistulas. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Peripheral Vascular Devices Market

One major factor propelling the peripheral vascular devices market is the increasing incidence of cardiovascular disorders, including deep vein thrombosis (DVT) and peripheral artery disease (PAD). The World Health Organization (WHO) states that heart disease is the primary cause of death globally. The need for peripheral vascular devices for detection and treatment is rising as a result of the rising prevalence of cardiovascular illnesses.

Restraints in the Global Peripheral Vascular Devices Market

One major barrier to commercial expansion for peripheral vascular devices is their high cost. The cost of research and development, legal regulations, and the use of cutting-edge materials and technologies are just a few of the reasons why these gadgets can be costly. These devices' high price may prevent them from being widely used, especially in poor nations with tight healthcare budgets and difficult reimbursement policies.

Market Trends of the Global Peripheral Vascular Devices Market

Drug-eluting devices are becoming more and more popular in the peripheral vascular devices market. By delivering therapeutic medications straight to the damaged blood arteries, these devices help avoid restenosis (re-narrowing) and lessen the need for repeated procedures. Drug-eluting stents, for instance, improve patients' long-term outcomes by releasing anti-proliferative medications to prevent the formation of scar tissue in the artery.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Peripheral Vascular Devices Market by Product Type

Market Overview
Angioplasty balloons
stents
embolic protection devices
peripheral vascular catheters
atherectomy devices
and vascular closure devices

Global Peripheral Vascular Devices Market by Application

Market Overview
Peripheral artery disease (PAD)
deep vein thrombosis (DVT)
varicose veins
and arteriovenous fistulas.

Global Peripheral Vascular Devices Market by End user

Market Overview
Hospitals
ambulatory surgical centers
and specialty clinics

Global Peripheral Vascular Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C.R. Bard (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTG plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spectranetics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments